Who owns ASCENTAGE PHARMA GROUP INTL?
- Ticker: AAPG
- CUSIP Number: 04390b105
Tip: Access positions for across all investors
Analyze quarterly positions in Ascentage Pharma Group Intl with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Ascentage Pharma Group Intl stock
Who bought or sold ASCENTAGE PHARMA GROUP INTL this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| UBS Group | 18k | $716k | 149% | Sep 2025 |
|
| XY Capital | 18k | $707k | 224% | Sep 2025 |
|
| Point72 | 18k | $700k | -14% | Sep 2025 |
|
| Tema Etfs | 10k | $405k | -33% | Sep 2025 |
|
| NEOS Investment Management | 10k | $412k | -33% | Sep 2025 |
|
| Citadel Advisors | 9.7k | $383k | 100% | Sep 2025 |
|
| Abc Arbitrage Sa | 5.2k | $204k | 100% | Sep 2025 |
|
| Mirae Asset Global Investments | 2.5k | $96k | 100% | Sep 2025 |
|
| Morgan Stanley | 956.00 | $38k | 100% | Jun 2025 |
|
| Tower Research Capital | 829.00 | $32k | 100% | Sep 2025 |
|
| Advisor Group Holdings | 220.00 | $8.5k | 100% | Sep 2025 |
|
| EverSource Wealth Advisors | 67.00 | $2.6k | 179% | Sep 2025 |
|
| Bell Investment Advisors | 67.00 | $2.6k | 0% | Sep 2025 |
|
Who sold out of Ascentage Pharma Group Intl?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Hsbc Holdings | Jun 2025 | 9.9k | $391k |
| Chevy Chase Trust Holdings | Jun 2025 | 5.8k | $227k |